Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome


Microcephaly-capillary malformation syndrome is a congenital and neurodevelopmental disorder caused by biallelic mutations in the STAMBP gene. Here we identify the novel homozygous mutation located in the SH3 binding motif of STAMBP (NM_006463.4) (c.707C>T: p.Ser236Phe) through whole-exome sequencing. The case patient was a 2-year-old boy showing severe global developmental delay, progressive microcephaly, refractory seizures, dysmorphic facial features, and multiple capillary malformations. Immunoblot analysis of patient-derived lymphoblastoid cell lines (LCLs) revealed a severe reduction in STAMBP expression, indicating that Ser236Phe induces protein instability. STAMBP interacts with the SH3 domain of STAM and transduces downstream signals from the Jaks-STAM complex. The substitution of Ser236Phe found in the case patient was located in the SH3-binding motif, and we propose the mutation may block STAM binding and subsequently induce STAMBP degradation. Contrary to previously reported STAMBP mutations, the Ser236Phe mutation did not lead to constitutive activation of the PI3K-AKT-mTOR pathway in patient-derived LCLs, as indicated by the expression of phosphorylated S6 ribosomal protein, suggesting that it is not the major pathomechanism underlying the disorder in this patient.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. 1.

    McDonell LM, Mirzaa GM, Alcantara D, Schwartzentruber J, Carter MT, Lee LJ, et al. Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome. Nat Genet. 2013;45:556–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. 2.

    Carter MT, Geraghty MT, De La Cruz L, Reichard RR, Boccuto L, Schwartz CE, et al. A new syndrome with multiple capillary malformations, intractable seizures, and brain and limb anomalies. Am J Med Genet A. 2011;155:301–6.

    Article  Google Scholar 

  3. 3.

    Mirzaa GM, Paciorkowski AR, Smyser CD, Willing MC, Lind AC, Dobyns WB. The microcephaly-capillary malformation syndrome. Am J Med Genet A. 2011;155:2080–7.

    Article  Google Scholar 

  4. 4.

    Isidor B, Barbarot S, Beneteau C, Le Caignec C, David A. Multiple capillary skin malformations, epilepsy, microcephaly, mental retardation, hypoplasia of the distal phalanges: report of a new case and further delineation of a new syndrome. Am J Med Genet A. 2011;155:1458–60.

    Article  Google Scholar 

  5. 5.

    Faqeih EA, Bastaki L, Rosti RO, Spencer EG, Zada AP, Saleh MA, et al. Novel STAMBP mutation and additional findings in an Arabic family. Am J Med Genet A. 2015;167:805–9.

    Article  CAS  Google Scholar 

  6. 6.

    Pavlovic M, Neubauer D, Al Tawari A, Heberle LC. The microcephaly-capillary malformation syndrome in two brothers with novel clinical features. Pediatr Neurol. 2014;51:560–5.

    Article  PubMed  Google Scholar 

  7. 7.

    Naseer MI, Sogaty S, Rasool M, Chaudhary AG, Abutalib YA, Walker S, et al. Microcephaly-capillary malformation syndrome: brothers with a homozygous STAMBP mutation, uncovered by exome sequencing. Am J Med Genet A. 2016;170:3018–22.

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Negishi Y, Miya F, Hattori A, Mizuno K, Hori I, Ando N, et al. Truncating mutation in NFIA causes brain malformation and urinary tract defects. Hum Genome Var. 2015;2:15007.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. 9.

    Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. 10.

    Sierra MI, Wright MH, Nash PD. AMSH interacts with ESCRT-0 to regulate the stability and trafficking of CXCR4. J Biol Chem. 2010;285:13990–4004.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. 11.

    Tanaka N, Kaneko K, Asao H, Kasai H, Endo Y, Fujita T, et al. Possible involvement of a novel STAM-associated molecule “AMSH” in intracellular signal transduction mediated by cytokines. J Biol Chem. 1999;274:19129–35.

    Article  PubMed  CAS  Google Scholar 

  12. 12.

    Suzuki S, Tamai K, Watanabe M, Kyuuma M, Ono M, Sugamura K, et al. AMSH is required to degrade ubiquitinated proteins in the central nervous system. Biochem Biophys Res Commun. 2011;408:582–8.

    Article  PubMed  CAS  Google Scholar 

  13. 13.

    Ishii N, Owada Y, Yamada M, Miura S, Murata K, Asao H, et al. Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient mice. Mol Cell Biol. 2001;21:8626–37.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. 14.

    Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131–45.

    Article  PubMed  CAS  Google Scholar 

  15. 15.

    Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355–69.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. 16.

    Lawson JA, Vogrin S, Bleasel AF, Cook MJ, Burns L, McAnally L, et al. Predictors of hippocampal, cerebral, and cerebellar volume reduction in childhood epilepsy. Epilepsia. 2000;41:1540–5.

    Article  PubMed  CAS  Google Scholar 

Download references


This study was supported in part by a grant for Research on Applying Health Technology from the Ministry of Health, Labour and Welfare of Japan to F.M., N.O., M.K., M.Y., Y.K., K.K., and SS.

Author information



Corresponding author

Correspondence to Shinji Saitoh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hori, I., Miya, F., Negishi, Y. et al. A novel homozygous missense mutation in the SH3-binding motif of STAMBP causing microcephaly-capillary malformation syndrome. J Hum Genet 63, 957–963 (2018).

Download citation


Quick links